(1) (a) The committee shall recommend placement of a substance in Schedule I if it finds: (i) that the substance has high potential for abuse; and (ii) that an accepted standard has not been established for safe use in treatment for medical purposes. (b) The committee may recommend placement of a substance in Schedule I under Section 58-37-4 if it finds that the substance is classified as a controlled substance in Schedule I under federal law.

(a) The committee shall recommend placement of a substance in Schedule I if it finds: (i) that the substance has high potential for abuse; and (ii) that an accepted standard has not been established for safe use in treatment for medical purposes.

(i) that the substance has high potential for abuse; and

(ii) that an accepted standard has not been established for safe use in treatment for medical purposes.

(b) The committee may recommend placement of a substance in Schedule I under Section 58-37-4 if it finds that the substance is classified as a controlled substance in Schedule I under federal law.

(2) (a) The committee shall recommend placement of a substance in Schedule II if it finds that: (i) the substance has high potential for abuse; (ii) the substance has a currently accepted medical use in treatment in the United States, or a currently accepted medical use subject to severe restrictions; and (iii) the abuse of the substance may lead to severe psychological or physiological dependence. (b) The committee may recommend placement of a substance in Schedule II if it finds that the substance is classified as a controlled substance in Schedule II under federal law.

(a) The committee shall recommend placement of a substance in Schedule II if it finds that: (i) the substance has high potential for abuse; (ii) the substance has a currently accepted medical use in treatment in the United States, or a currently accepted medical use subject to severe restrictions; and (iii) the abuse of the substance may lead to severe psychological or physiological dependence.

(i) the substance has high potential for abuse;

(ii) the substance has a currently accepted medical use in treatment in the United States, or a currently accepted medical use subject to severe restrictions; and

(iii) the abuse of the substance may lead to severe psychological or physiological dependence.

(b) The committee may recommend placement of a substance in Schedule II if it finds that the substance is classified as a controlled substance in Schedule II under federal law.

(3) (a) The committee shall recommend placement of a substance in Schedule III if it finds that: (i) the substance has a potential for abuse that is less than the potential for substances listed in Schedules I and II; (ii) the substance has a currently accepted medical use in treatment in the United States; and (iii) abuse of the substance may lead to moderate or low physiological dependence or high psychological dependence. (b) The committee may recommend placement of a substance in Schedule III if it finds that the substance is classified as a controlled substance in Schedule III under federal law.

(a) The committee shall recommend placement of a substance in Schedule III if it finds that: (i) the substance has a potential for abuse that is less than the potential for substances listed in Schedules I and II; (ii) the substance has a currently accepted medical use in treatment in the United States; and (iii) abuse of the substance may lead to moderate or low physiological dependence or high psychological dependence.

(i) the substance has a potential for abuse that is less than the potential for substances listed in Schedules I and II;

(ii) the substance has a currently accepted medical use in treatment in the United States; and

(iii) abuse of the substance may lead to moderate or low physiological dependence or high psychological dependence.

(b) The committee may recommend placement of a substance in Schedule III if it finds that the substance is classified as a controlled substance in Schedule III under federal law.

(4) (a) The committee shall recommend placement of a substance in Schedule IV if it finds that: (i) the substance has a low potential for abuse relative to substances in Schedule III; (ii) the substance has currently accepted medical use in treatment in the United States; and (iii) abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III. (b) The committee may recommend placement of a substance in Schedule IV if it finds that the substance is classified as a controlled substance in Schedule IV under federal law.

(a) The committee shall recommend placement of a substance in Schedule IV if it finds that: (i) the substance has a low potential for abuse relative to substances in Schedule III; (ii) the substance has currently accepted medical use in treatment in the United States; and (iii) abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III.

(i) the substance has a low potential for abuse relative to substances in Schedule III;

(ii) the substance has currently accepted medical use in treatment in the United States; and

(iii) abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III.

(b) The committee may recommend placement of a substance in Schedule IV if it finds that the substance is classified as a controlled substance in Schedule IV under federal law.

(5) (a) The committee shall recommend placement of a substance in Schedule V if it finds that: (i) the substance has low potential for abuse relative to the controlled substances listed in Schedule IV; (ii) the substance has currently accepted medical use in treatment in the United States; and (iii) the substance has limited physiological dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV. (b) The committee may recommend placement of a substance in Schedule V under this chapter if it finds that the substance is classified as a controlled substance in Schedule V under federal law.

(a) The committee shall recommend placement of a substance in Schedule V if it finds that: (i) the substance has low potential for abuse relative to the controlled substances listed in Schedule IV; (ii) the substance has currently accepted medical use in treatment in the United States; and (iii) the substance has limited physiological dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV.

(i) the substance has low potential for abuse relative to the controlled substances listed in Schedule IV;

(ii) the substance has currently accepted medical use in treatment in the United States; and

(iii) the substance has limited physiological dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV.

(b) The committee may recommend placement of a substance in Schedule V under this chapter if it finds that the substance is classified as a controlled substance in Schedule V under federal law.

(6) The committee may recommend placement of a substance on a controlled substance list if it finds that the substance has a potential for abuse and that an accepted standard has not been established for safe use in treatment for medical purposes.